Structural and functional basis of the developmental regulation of human coagulation factor IX gene: factor IX Leyden.
AUTOR(ES)
Hirosawa, S
RESUMO
Hemophilia B Leyden is characterized by unusual developmental regulation of factor IX synthesis in affected individuals. One family affected with the hemophilia B Leyden phenotype was found to have a specific single-base mutation (G----A) at nucleotide -6 of the factor IX gene. The mutation site was found in a small region of the 5'-untranslated sequence designated the Leyden-specific region (LS region). This region, approximately 40 base pairs in length, contains the unique mutation sites of all the known factor IX Leyden genes (five families) analyzed to date. This fact strongly suggests that the LS region is directly or indirectly involved in the developmental regulation of factor IX biosynthesis. Base changes at nucleotide -20 as well as at nucleotide -6 and deletions of the 3' half of the LS region reduced expression activity of the factor IX gene to approximately 15-31% that of the normal control, as assessed in a cultured cell (HepG2) expression system. The LS region binds at least two proteins. Androgen significantly increased the transcriptional activities of both mutant and normal factor IX genes in a concentration-dependent manner.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=54126Documentos Relacionados
- Structural basis for chemical inhibition of human blood coagulation factor Xa
- A less severe form of Haemophilia B Leyden.
- Disruption of a binding site for hepatocyte nuclear factor 4 results in hemophilia B Leyden.
- Kinetics of the Factor XIa catalyzed activation of human blood coagulation Factor IX.
- Regional localization on the human X chromosome and polymorphism of the coagulation factor IX gene (hemophilia B locus).